Crinetics Pharmaceuticals, Inc. Debt Securities Available For Sale Excluding Accrued Interest
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities Available For Sale Excluding Accrued Interest of $1.15 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-03
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $1.15B.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $1.18B.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $926.35M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $981.39M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $1.15B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.18B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $926.35M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $981.39M 10-Q · filed 2025-11-06 |
| 2024-12-31 | $1.09B 10-K · filed 2026-02-26 |